ContractResearch License and Option Agreement • January 12th, 2021
Contract Type FiledJanuary 12th, 2021Sarepta Therapeutics and Selecta Biosciences Enter Into Research License and Option Agreement for Selecta’s ImmTOR Immune Tolerance Platform in Neuromuscular Diseases
ContractResearch License and Option Agreement • June 18th, 2020
Contract Type FiledJune 18th, 2020Sarepta Therapeutics and Selecta Biosciences Enter into Research License and Option Agreement for Selecta’s ImmTOR Immune Tolerance Platform in Neuromuscular Diseases